Skip to content

Nxlink, Ltd.

Country not established

Devices
1

What Nxlink, Ltd. makes

Nxlink, Ltd. manufactures neurometric analysis systems designed for evaluating neural activity and functional metrics in clinical or research settings. These systems are intended to provide quantitative assessments of neurological responses, supporting diagnostic or monitoring applications.

The company’s neurometric analysis systems are classified as Class II devices under FDA regulations and are listed via the 510(k) pathway. These products are registered in the United States, where the manufacturer is based.

AI-generated from registry data, 2 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue1

Newest first, rows 1-1 of 1

  • Neurometric Analysis System Ref K974748

    Active Regimes: 510(k) Registry: 510(k) Class:II

Frequently asked questions

How many devices does Nxlink, Ltd. have in the registry?

The registry currently lists 1 device for Nxlink, Ltd.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Nxlink, Ltd.'s devices?

Among its 1 most recently registered device, Nxlink, Ltd. has devices listed in FDA 510(k) (1 device).

What risk classes do Nxlink, Ltd.'s devices fall under?

Among its 1 most recently registered device, the classes recorded for Nxlink, Ltd.'s devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from Nxlink, Ltd. in the registry?

The most recently registered devices listed for Nxlink, Ltd. include NEUROMETRIC ANALYSIS SYSTEM.

Generated automatically from registry data and not verified by a human reviewer.